Asset Details
MbrlCatalogueTitleDetail
Do you wish to reserve the book?
Hydroxyurea—The Good, the Bad and the Ugly
by
Musiałek, Marcelina W.
, Rybaczek, Dorota
in
Alzheimer's disease
/ anemia
/ Animals
/ Brain cancer
/ Catalysis
/ Cell cycle
/ Cell death
/ Cognitive ability
/ cognitive disorders
/ Cytotoxicity
/ DNA damage
/ DNA Replication - drug effects
/ Enzymes
/ Humans
/ Hydroxyurea
/ Hydroxyurea - metabolism
/ Hydroxyurea - pharmacology
/ Hydroxyurea - therapeutic use
/ ingredients
/ Kinases
/ Myeloproliferative diseases
/ neoplasm progression
/ Neurodegenerative diseases
/ Organisms
/ Oxidative stress
/ Regulation
/ Replication
/ Review
/ Ribonucleotide reductase
/ Ribonucleotide Reductases - antagonists & inhibitors
/ Ribonucleotide Reductases - metabolism
/ S Phase - drug effects
/ Skin cancer
/ skin neoplasms
/ therapeutics
2021
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
You are currently in the queue to collect this book. You will be notified once it is your turn to collect the book.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Hydroxyurea—The Good, the Bad and the Ugly
by
Musiałek, Marcelina W.
, Rybaczek, Dorota
in
Alzheimer's disease
/ anemia
/ Animals
/ Brain cancer
/ Catalysis
/ Cell cycle
/ Cell death
/ Cognitive ability
/ cognitive disorders
/ Cytotoxicity
/ DNA damage
/ DNA Replication - drug effects
/ Enzymes
/ Humans
/ Hydroxyurea
/ Hydroxyurea - metabolism
/ Hydroxyurea - pharmacology
/ Hydroxyurea - therapeutic use
/ ingredients
/ Kinases
/ Myeloproliferative diseases
/ neoplasm progression
/ Neurodegenerative diseases
/ Organisms
/ Oxidative stress
/ Regulation
/ Replication
/ Review
/ Ribonucleotide reductase
/ Ribonucleotide Reductases - antagonists & inhibitors
/ Ribonucleotide Reductases - metabolism
/ S Phase - drug effects
/ Skin cancer
/ skin neoplasms
/ therapeutics
2021
Oops! Something went wrong.
While trying to remove the title from your shelf something went wrong :( Kindly try again later!
Do you wish to request the book?
Hydroxyurea—The Good, the Bad and the Ugly
by
Musiałek, Marcelina W.
, Rybaczek, Dorota
in
Alzheimer's disease
/ anemia
/ Animals
/ Brain cancer
/ Catalysis
/ Cell cycle
/ Cell death
/ Cognitive ability
/ cognitive disorders
/ Cytotoxicity
/ DNA damage
/ DNA Replication - drug effects
/ Enzymes
/ Humans
/ Hydroxyurea
/ Hydroxyurea - metabolism
/ Hydroxyurea - pharmacology
/ Hydroxyurea - therapeutic use
/ ingredients
/ Kinases
/ Myeloproliferative diseases
/ neoplasm progression
/ Neurodegenerative diseases
/ Organisms
/ Oxidative stress
/ Regulation
/ Replication
/ Review
/ Ribonucleotide reductase
/ Ribonucleotide Reductases - antagonists & inhibitors
/ Ribonucleotide Reductases - metabolism
/ S Phase - drug effects
/ Skin cancer
/ skin neoplasms
/ therapeutics
2021
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Hydroxyurea—The Good, the Bad and the Ugly
2021
Request Book From Autostore
and Choose the Collection Method
Overview
Hydroxyurea (HU) is mostly referred to as an inhibitor of ribonucleotide reductase (RNR) and as the agent that is commonly used to arrest cells in the S-phase of the cycle by inducing replication stress. It is a well-known and widely used drug, one which has proved to be effective in treating chronic myeloproliferative disorders and which is considered a staple agent in sickle anemia therapy and—recently—a promising factor in preventing cognitive decline in Alzheimer’s disease. The reversibility of HU-induced replication inhibition also makes it a common laboratory ingredient used to synchronize cell cycles. On the other hand, prolonged treatment or higher dosage of hydroxyurea causes cell death due to accumulation of DNA damage and oxidative stress. Hydroxyurea treatments are also still far from perfect and it has been suggested that it facilitates skin cancer progression. Also, recent studies have shown that hydroxyurea may affect a larger number of enzymes due to its less specific interaction mechanism, which may contribute to further as-yet unspecified factors affecting cell response. In this review, we examine the actual state of knowledge about hydroxyurea and the mechanisms behind its cytotoxic effects. The practical applications of the recent findings may prove to enhance the already existing use of the drug in new and promising ways.
Publisher
MDPI AG,MDPI
This website uses cookies to ensure you get the best experience on our website.